TABLE 2.
Multiple linear regression analysis of risk factors for hypertension with ischemic stroke
| Independent variable | Hypertension with ischemic stroke | ||||
|---|---|---|---|---|---|
| β value | SE | Wald χ2 | p‐value | OR (95% CI) | |
| CTLA‐4 | 0.244 | 0.069 | 12.771 | 0.001 | 1.276 (1.117~1.459) |
| IMA | 0.195 | 0.078 | 6.250 | 0.009 | 1.213 (1.041~1.414) |
| Lp‐PLA2 | 0.142 | 0.051 | 7.863 | 0.004 | 1.152 (1.042~1.274) |
| GFAP | 0.134 | 0.062 | 4.591 | 0.032 | 1.145 (1.012~1.295) |
| HCY | 0.152 | 0.086 | 6.975 | <0.001 | 1.552 (1.156~2.937) |
| Age | 0.173 | 0.132 | 1.727 | 0.187 | 1.191 (0.916~1.556) |
| Gender | 0.142 | 0.127 | 1.282 | 0.256 | 1.158 (0.904~1.487) |
| Smoking | 0.013 | 0.126 | 0.011 | 0.918 | 1.013 (0.791~1.297) |
| Drinking | 0.069 | 0.083 | 0.691 | 0.406 | 1.071 (0.911~1.261) |
| Body mass index | 0.023 | 0.109 | 0.045 | 0.833 | 1.023 (0.826~1.267) |
| Diabetes | 0.018 | 0.127 | 0.029 | 0.862 | 1.026 (0.895~1.275) |
Abbreviation: OR, odd ratio; CI, confidence interval; CTLA‐4, cytotoxic T lymphocyte‐associated antigen‐4; IMA, ischemia‐modified albumin; IL‐1α, interleukin‐1 alpha; IL‐2: interleukin‐2; MIP: macrophage inflammatory protein; HCY: homocysteine; Lp‐PLA2: lipoprotein‐associated phospholipase A2; GFAP: glial fibrillary acidic protein.